Atlas Trials

Predictive Value of Maternal Serum Pentraxin 3 (PTX 3) and Heparin-binding Protein (HBP) for Chorioamnionitis in Preterm Premature Rupture of Membranes

Clinical trial NCT05207800 · UNKNOWN

Trial details

NCT number
NCT05207800
Sponsor
Second Affiliated Hospital of Wenzhou Medical University
Status
UNKNOWN
Study type
OBSERVATIONAL
Preterm Premature Rupture of Membrane
Start date
2022-02-10
Primary completion
2022-12-31
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.